|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,330 KRW | -0.37% |
|
-1.11% | -14.58% |
| 2023 | Sinsin Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2017 | Sinsin Pharm. Co., Ltd. has completed an IPO in the amount of KRW 14.625 billion. | CI |
Sinsin Pharmaceutical Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 53.5 million compared to KRW 50.1 million a year ago. Net income was KRW 735.37 million compared to KRW 466.86 million a year ago.
Basic earnings per share from continuing operations was KRW 49 compared to KRW 31 a year ago. Basic earnings per share was KRW 49 compared to KRW 31 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.58% | 58.47M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
SINSIN PHARMACEUTICAL CO., LTD 
